UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex

Cell, 2019-01, Vol.176 (3), p.448-458.e12

2019

Volltextzugriff (PDF)

The therapeutic potential of sigma (σ) receptors for the treatment of central nervous system diseases: evaluation of the evidence

Current pharmaceutical design, 2012-03, Vol.18 (7), p.884-901

2012

Volltextzugriff (PDF)

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution

New Psychoactive Substances, 2018, Vol.252, p.191-226

2018

Volltextzugriff (PDF)

Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A‑CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA

ACS chemical neuroscience, 2020-12, Vol.11 (24), p.4434-4446

2020

Volltextzugriff (PDF)

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

ACS chemical neuroscience, 2015-09, Vol.6 (9), p.1546-1559

2015

Volltextzugriff (PDF)

Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome

PloS one, 2023-01, Vol.18 (1), p.e0280842

2023

Volltextzugriff (PDF)

Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples

Drug testing and analysis, 2018-01, Vol.10 (1), p.196-205

2018

Volltextzugriff (PDF)

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

Frontiers in psychiatry, 2022-12, Vol.13, p.1048836-1048836

2022

Volltextzugriff (PDF)

[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats

PloS one, 2013-02, Vol.8 (2), p.e56441-e56441

2013

Volltextzugriff (PDF)

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays: Part I—Synthesis, analytical characterization, and binding affinity for human CB1 receptors

Drug testing and analysis, 2021-07, Vol.13 (7), p.1383-1401

2021

Volltextzugriff (PDF)

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy

Frontiers in physiology, 2023-04, Vol.14, p.1086243-1086243

2023

Volltextzugriff (PDF)

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist

Frontiers in pharmacology, 2019-05, Vol.10, p.595

2019

Volltextzugriff (PDF)

Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists

Biochemical pharmacology, 2019-11, Vol.169, p.113623, Article 113623

2019

Volltextzugriff (PDF)

Systematic evaluation of a panel of 30 synthetic cannabinoid receptor agonists structurally related to MMB‐4en‐PICA, MDMB‐4en‐PINACA, ADB‐4en‐PINACA, and MMB‐4CN‐BUTINACA using a combination of binding and different CB1 receptor activation assays. Part III: The G protein pathway and critical comparison of different assays

Drug testing and analysis, 2021-07, Vol.13 (7), p.1412-1429

2021

Volltextzugriff (PDF)

Selective modulation of the cannabinoid type 1 (CB) receptor as an emerging platform for the treatment of neuropathic pain

MedChemComm, 2019-05, Vol.1 (5), p.647-659

2019

Volltextzugriff (PDF)

“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York

The New England journal of medicine, 2017-01, Vol.376 (3), p.235-242

2017

Volltextzugriff (PDF)

Characterisation of AMB-FUBINACA metabolism and CB1-mediated activity of its acid metabolite

Forensic toxicology, 2023-01, Vol.41 (1), p.114-125

2023

Volltextzugriff (PDF)

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor

Pharmacology research & perspectives, 2023-12, Vol.11 (6), p.e01157-n/a

2023

Volltextzugriff (PDF)

Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition

Brain, behavior, and immunity, 2014-10, Vol.41, p.173-181

2014

Volltextzugriff (PDF)

The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities

Forensic toxicology, 2016-07, Vol.34 (2), p.286-303

2016

Volltextzugriff (PDF)

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs

Frontiers in psychiatry, 2022-09, Vol.13, p.1010501

2022

Volltextzugriff (PDF)

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins

New Psychoactive Substances, 2018, Vol.252, p.165-190

2018

Volltextzugriff (PDF)

The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse

ACS chemical neuroscience, 2013-07, Vol.4 (7), p.1081-1092

2013

Volltextzugriff (PDF)

The Recent Development of α 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

Current pharmaceutical design, 2016-04, Vol.22 (14), p.2134-2151

2016

Volltextzugriff (PDF)

In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors

British journal of pharmacology, 2019-12, Vol.176 (24), p.4653-4665

2019

Volltextzugriff (PDF)

1 – 25 von 122

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(120)
Mit Volltextzugriff
(113)

Publikationsform

Artikel
(120)
Buchkapitel
(2)

Sprache

Erscheinungsjahr

n.n

Thema

Science & Technology
(79)
Life Sciences & Biomedicine
(70)
Pharmacology & Pharmacy
(55)
Humans
(36)
Chemistry
(32)
Chemistry, Medicinal
(32)
Biochemistry & Molecular Biology
(31)
Animals
(30)
Physical Sciences
(26)
Cannabinoid
(19)
Ligands
(19)
Neurosciences
(18)
Neurosciences & Neurology
(17)
Structure-Activity Relationship
(17)
Cannabinoid Receptor Agonists - Pharmacology
(14)
Pharmacology
(14)
Rats
(14)
Cannabinoids - Pharmacology
(13)
Indazoles - Pharmacology
(13)
Male
(13)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Structure of a Signaling Cannabinoid Receptor 1-G Protein Complex

The therapeutic potential of sigma (σ) receptors for the treatment of central nervous system diseases: evaluation of the evidence

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonist New Psychoactive Substances: Evolution

Synthesis and in Vitro Cannabinoid Receptor 1 Activity of Recently Detected Synthetic Cannabinoids 4F-MDMB-BICA, 5F-MPP-PICA, MMB-4en-PICA, CUMYL-CBMICA, ADB-BINACA, APP-BINACA, 4F-MDMB-BINACA, MDMB-4en-PINACA, A‑CHMINACA, 5F-AB-P7AICA, 5F-MDMB-P7AICA, and 5F-AP7AICA

Pharmacology of Indole and Indazole Synthetic Cannabinoid Designer Drugs AB-FUBINACA, ADB-FUBINACA, AB-PINACA, ADB-PINACA, 5F-AB-PINACA, 5F-ADB-PINACA, ADBICA, and 5F-ADBICA

Heterozygous deletion of Gpr55 does not affect a hyperthermia-induced seizure, spontaneous seizures or survival in the Scn1a+/- mouse model of Dravet syndrome

Detection of the recently emerged synthetic cannabinoid 5F–MDMB‐PICA in ‘legal high’ products and human urine samples

Off-target pharmacological profiling of synthetic cannabinoid receptor agonists including AMB-FUBINACA, CUMYL-PINACA, PB-22, and XLR-11

[18F]DPA-714: direct comparison with [11C]PK11195 in a model of cerebral ischemia in rats

MEPIRAPIM-derived synthetic cannabinoids inhibit T-type calcium channels with divergent effects on seizures in rodent models of epilepsy

CUMYL-4CN-BINACA Is an Efficacious and Potent Pro-Convulsant Synthetic Cannabinoid Receptor Agonist

Insights into biased signaling at cannabinoid receptors: synthetic cannabinoid receptor agonists

Selective modulation of the cannabinoid type 1 (CB) receptor as an emerging platform for the treatment of neuropathic pain

“Zombie” Outbreak Caused by the Synthetic Cannabinoid AMB-FUBINACA in New York

Characterisation of AMB-FUBINACA metabolism and CB1-mediated activity of its acid metabolite

Evaluating signaling bias for synthetic cannabinoid receptor agonists at the cannabinoid CB2 receptor

Effect of maternal immune activation on the kynurenine pathway in preadolescent rat offspring and on MK801-induced hyperlocomotion in adulthood: Amelioration by COX-2 inhibition

The 2-alkyl-2H-indazole regioisomers of synthetic cannabinoids AB-CHMINACA, AB-FUBINACA, AB-PINACA, and 5F-AB-PINACA are possible manufacturing impurities with cannabimimetic activities

Synthesis and pharmacological evaluation of newly detected synthetic cannabinoid receptor agonists AB-4CN-BUTICA, MMB-4CN-BUTINACA, MDMB-4F-BUTICA, MDMB-4F-BUTINACA and their analogs

The Chemistry and Pharmacology of Synthetic Cannabinoid Receptor Agonists as New Psychoactive Substances: Origins

The Synthesis and Pharmacological Evaluation of Adamantane-Derived Indoles: Cannabimimetic Drugs of Abuse

The Recent Development of α 7 Nicotinic Acetylcholine Receptor (nAChR) Ligands as Therapeutic Candidates for the Treatment of Central Nervous System (CNS) Diseases

In vitro determination of the efficacy of illicit synthetic cannabinoids at CB1 receptors

Suchergebnisse filtern